Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.
DSpace Repository
- Home
- Law
- NEW JERSEY LEGISLATIVE HISTORIES
- 2016
- View Item
Digital Jerseyana Collection | New Jersey State Publications Digital Library | About NJ Digital Collections
Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.
| Title: | Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.; Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements. |
| Author: | Compiled by the New Jersey State Library |
| Abstract: | Year: 2016; Chapter: 73 |
| URI: | http://hdl.handle.net/10929.1/26498 |
Files in this item
| Files | Size | Format | View | Description |
|---|---|---|---|---|
| L2016c73.pdf | 1.658Mb |
|
L2016c73 |
This item appears in the following Collection(s)
-
2016
New Jersey Legislative Histories from 2016
Related items
Showing items related by title, author, creator and subject.
-
Year: 1974; Chapter: 50 -
Untitled Year: 2007; Chapter: 154
-
